Literature DB >> 18460914

N-3 polyunsaturated fatty acid regulation of hepatic gene transcription.

Donald B Jump1.   

Abstract

PURPOSE OF REVIEW: The liver plays a central role in whole body lipid metabolism and adapts rapidly to changes in dietary fat composition. This adaption involves changes in the expression of genes involved in glycolysis, de-novo lipogenesis, fatty acid elongation, desaturation and oxidation. This review brings together metabolic and molecular studies that help explain n-3 (omega-3) polyunsaturated fatty acid regulation of hepatic gene transcription. RECENT
FINDINGS: Dietary n-3 polyunsaturated fatty acid regulates hepatic gene expression by targeting three major transcriptional regulatory networks: peroxisome proliferator-activated receptor alpha, sterol regulatory element binding protein-1 and the carbohydrate regulatory element binding protein/Max-like factor X heterodimer. 22:6,n-3, the most prominent n-3 polyunsaturated fatty acid in tissues, is a weak activator of peroxisome proliferator-activated receptor alpha. Hepatic metabolism of 22:6,n-3, however, generates 20:5,n-3, a strong peroxisome proliferator-activated receptor alpha activator. In contrast to peroxisome proliferator-activated receptor alpha, 22:6,n-3 is the most potent fatty acid regulator of hepatic sterol regulatory element binding protein-1. 22:6,n-3 suppresses sterol regulatory element binding protein-1 gene expression while enhancing degradation of nuclear sterol regulatory element binding protein-1 through 26S proteasome and Erk1/2-dependent mechanisms. Both n-3 and n-6 polyunsaturated fatty acid suppress carbohydrate regulatory element binding protein and Max-like factor X nuclear abundance and interfere with glucose-regulated hepatic metabolism.
SUMMARY: These studies have revealed unique mechanisms by which specific polyunsaturated fatty acids control peroxisome proliferator activated receptor alpha, sterol regulatory element binding protein-1 and carbohydrate regulatory element binding protein/Max-like factor X function. As such, specific metabolic and signal transduction pathways contribute significantly to the fatty acid regulation of these transcription factors and their corresponding regulatory networks.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18460914      PMCID: PMC2764370          DOI: 10.1097/MOL.0b013e3282ffaf6a

Source DB:  PubMed          Journal:  Curr Opin Lipidol        ISSN: 0957-9672            Impact factor:   4.776


  47 in total

1.  Upregulated liver conversion of alpha-linolenic acid to docosahexaenoic acid in rats on a 15 week n-3 PUFA-deficient diet.

Authors:  Miki Igarashi; James C DeMar; Kaizong Ma; Lisa Chang; Jane M Bell; Stanley I Rapoport
Journal:  J Lipid Res       Date:  2006-10-18       Impact factor: 5.922

2.  Phosphorylation and ubiquitination of the transcription factor sterol regulatory element-binding protein-1 in response to DNA binding.

Authors:  Tanel Punga; Maria T Bengoechea-Alonso; Johan Ericsson
Journal:  J Biol Chem       Date:  2006-07-06       Impact factor: 5.157

3.  The nuclear receptor LXR is a glucose sensor.

Authors:  Nico Mitro; Puiying A Mak; Leo Vargas; Cristina Godio; Eric Hampton; Valentina Molteni; Andreas Kreusch; Enrique Saez
Journal:  Nature       Date:  2006-12-24       Impact factor: 49.962

4.  Eicosapentaenoic acid actions on adiposity and insulin resistance in control and high-fat-fed rats: role of apoptosis, adiponectin and tumour necrosis factor-alpha.

Authors:  Patricia Pérez-Matute; Nerea Pérez-Echarri; J Alfredo Martínez; Amelia Marti; María J Moreno-Aliaga
Journal:  Br J Nutr       Date:  2007-02       Impact factor: 3.718

5.  Dietary n-3 PUFA deprivation for 15 weeks upregulates elongase and desaturase expression in rat liver but not brain.

Authors:  Miki Igarashi; Kaizong Ma; Lisa Chang; Jane M Bell; Stanley I Rapoport
Journal:  J Lipid Res       Date:  2007-08-22       Impact factor: 5.922

6.  Identification and function of phosphorylation in the glucose-regulated transcription factor ChREBP.

Authors:  Nikolas G Tsatsos; Michael N Davies; Brennon L O'Callaghan; Howard C Towle
Journal:  Biochem J       Date:  2008-04-15       Impact factor: 3.857

7.  Glycogen synthase kinase 3alpha-specific regulation of murine hepatic glycogen metabolism.

Authors:  Katrina MacAulay; Bradley W Doble; Satish Patel; Tanya Hansotia; Elaine M Sinclair; Daniel J Drucker; Andras Nagy; James R Woodgett
Journal:  Cell Metab       Date:  2007-10       Impact factor: 27.287

Review 8.  ChREBP, a transcriptional regulator of glucose and lipid metabolism.

Authors:  Catherine Postic; Renaud Dentin; Pierre-Damien Denechaud; Jean Girard
Journal:  Annu Rev Nutr       Date:  2007       Impact factor: 11.848

9.  The liver X receptor (LXR) and hepatic lipogenesis. The carbohydrate-response element-binding protein is a target gene of LXR.

Authors:  Ji-Young Cha; Joyce J Repa
Journal:  J Biol Chem       Date:  2006-11-14       Impact factor: 5.157

10.  Regulation of hepatic fatty acid elongase and desaturase expression in diabetes and obesity.

Authors:  Yun Wang; Daniela Botolin; Jinghua Xu; Barbara Christian; Ernestine Mitchell; Bolleddula Jayaprakasam; Muraleedharan G Nair; Muraleedharan Nair; Jeffrey M Peters; Jeffery M Peters; Julia V Busik; Julia Busik; L Karl Olson; Donald B Jump
Journal:  J Lipid Res       Date:  2006-06-21       Impact factor: 5.922

View more
  122 in total

1.  Docosahexaenoic Acid and Eicosapentaenoic Acid Did not Alter trans-10,cis-12 Conjugated Linoleic Acid Incorporation into Mice Brain and Eye Lipids.

Authors:  Madhuri Vemuri; Yuriko Adkins; Bruce E Mackey; Darshan S Kelley
Journal:  Lipids       Date:  2017-08-04       Impact factor: 1.880

2.  Inducing effect of clofibric acid on stearoyl-CoA desaturase in intestinal mucosa of rats.

Authors:  Tohru Yamazaki; Makiko Kadokura; Yuki Mutoh; Takeshi Sakamoto; Mari Okazaki; Atsushi Mitsumoto; Yoichi Kawashima; Naomi Kudo
Journal:  Lipids       Date:  2014-11-02       Impact factor: 1.880

3.  Clinical correlates and heritability of erythrocyte eicosapentaenoic and docosahexaenoic acid content in the Framingham Heart Study.

Authors:  William S Harris; James V Pottala; Sean M Lacey; Ramachandran S Vasan; Martin G Larson; Sander J Robins
Journal:  Atherosclerosis       Date:  2012-06-07       Impact factor: 5.162

Review 4.  Recent advances in dietary supplementation, in treating non-alcoholic fatty liver disease.

Authors:  Tannaz Eslamparast; Sareh Eghtesad; Hossein Poustchi; Azita Hekmatdoost
Journal:  World J Hepatol       Date:  2015-02-27

Review 5.  (n-3) fatty acids and cardiovascular health: are effects of EPA and DHA shared or complementary?

Authors:  Dariush Mozaffarian; Jason H Y Wu
Journal:  J Nutr       Date:  2012-01-25       Impact factor: 4.798

6.  Soraphen A, an inhibitor of acetyl CoA carboxylase activity, interferes with fatty acid elongation.

Authors:  Donald B Jump; Moises Torres-Gonzalez; L Karl Olson
Journal:  Biochem Pharmacol       Date:  2010-12-22       Impact factor: 5.858

Review 7.  Nutritional approaches for managing obesity-associated metabolic diseases.

Authors:  Rachel Botchlett; Shih-Lung Woo; Mengyang Liu; Ya Pei; Xin Guo; Honggui Li; Chaodong Wu
Journal:  J Endocrinol       Date:  2017-04-11       Impact factor: 4.286

8.  Double-blind randomized placebo-controlled clinical trial of omega 3 fatty acids for the treatment of diabetic patients with nonalcoholic steatohepatitis.

Authors:  Srinivasan Dasarathy; Jaividhya Dasarathy; Amer Khiyami; Lisa Yerian; Carol Hawkins; Ruth Sargent; Arthur J McCullough
Journal:  J Clin Gastroenterol       Date:  2015-02       Impact factor: 3.062

Review 9.  Pathways of polyunsaturated fatty acid utilization: implications for brain function in neuropsychiatric health and disease.

Authors:  Joanne J Liu; Pnina Green; J John Mann; Stanley I Rapoport; M Elizabeth Sublette
Journal:  Brain Res       Date:  2014-12-08       Impact factor: 3.252

10.  A PUFA-rich diet improves fat oxidation following saturated fat-rich meal.

Authors:  Jada L Stevenson; Mary K Miller; Hannah E Skillman; Chad M Paton; Jamie A Cooper
Journal:  Eur J Nutr       Date:  2016-05-18       Impact factor: 5.614

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.